Trials / Completed
CompletedNCT00403624
Evaluation of the Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy in Rectal Cancer
Clinical Study to Evaluate a Protocol of Oxaliplatin -UFT- Radiotherapy for the Neoadjuvant Treatment Rectal Cancer
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 38 (planned)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Primary objective: \- To evaluate the rate of responses to neoadjuvant therapy + radiotherapy Secondary objective: \- tolerability (toxicity) and time to progression
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OXALIPLATIN |
Timeline
- Start date
- 2001-07-01
- Primary completion
- 2005-11-01
- Completion
- 2005-11-01
- First posted
- 2006-11-27
- Last updated
- 2010-08-27
Source: ClinicalTrials.gov record NCT00403624. Inclusion in this directory is not an endorsement.